SCHEMBL20745442

SCHEMBL20745442

O=C(O)c1ccccc1-c1nccc(CO)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ ALDH1A1 P00352 4/20 0.40
▸ KDM4C Q9H3R0 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ HNF4A P41235 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ SHMT1 P34896 1/20 0.38
▸ SHMT2 P34897 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ MYC P01106 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ HMGB1 P09429 1/20 0.38
▸ HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22262804 0.80 SHMT1 (0.39) ALDH1A1KDM4CKDM4ESHMT1SHMT2
SCHEMBL20742140 0.78 TDP1 (0.41) RAB9AALDH1A1KDM4EHTTLMNA
SCHEMBL465563 0.78 KDM4E (0.55) RAB9ANPC1ALDH1A1KDM4CKDM4E
SCHEMBL20742130 0.78 SMN1; SMN2 (0.44) ALDH1A1KDM4EHTTLMNAALOX12
SCHEMBL20745407 0.77 L3MBTL1 (0.50) ALDH1A1KDM4EHTTLMNATDP1
SCHEMBL20742137 0.77 CYP1A2 (0.40) RAB9AALDH1A1KDM4EHTTLMNA
SCHEMBL20742720 0.76 CYP1A2 (0.34) ALDH1A1KDM4ETDP1SHMT1SHMT2
SCHEMBL16815386 0.76 ALDH1A1 (0.37) RAB9ANPC1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL7958916 0.75 TRPV3 (0.45) RAB9ANPC1KDM4ESMN1; SMN2SHMT1
SCHEMBL3942454 0.74 RAB9A (0.57) RAB9ANPC1ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3668502-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE AbbVie Inc. (US) 2020-06-24 — — EP disclosed
WO-2019035927-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC. (US) 2019-02-21 — — WO disclosed
Send feedback